In today’s episode, we’re diving into the world of GLP-1 medications like Ozempic and Wegovy. Sam is joined by guest Dr. Asher Larmie (he/they), a transmasculine general practitioner and expert in weight stigma.  Sam and Asher tackle the complexities and nuances surrounding these popular medications.  They explore their impact on weight loss, management of type 2 diabetes, and the long-term relationship with our health. Asher brings up concerns over the use of these drugs in nondiabetic individuals, the risks that accompany their benefits, and the importance of informed consent in medical treatment. Today’s conversation isn’t just about medication—it’s about empowerment, offering personal insights, and the right to autonomy in medical decisions. We’ll discuss the unforeseen consequences of pathologizing weight and how a history of weight stigma has led to delayed diagnoses and a plethora of physical and mental health challenges. In this episode, we discuss: How Asher became a weight-inclusive physicianWhen a GLP-1 agonist may be beneficial for PCOSThe risks and side effects of these medicationsWhat the research says about Wegovy and weight lossTips for talking to your doctor about semaglutideSo, listeners, sit back, open your hearts and minds, and let’s get nourished with the knowledge and experiences shared in our discussion with Asher Larmie on Ozempic, Wegovy, and their use for weight loss. Please visit our podcast page for the show notes, study information, and Asher’s contact information. Download your FREE intuitive eating workbook! Ready to have more food freedom with PCOS? Download this free workbook to help you apply the intuitive eating framework to PCOS management and symptoms. Follow Sam on Instagram: https://www.instagram.com/pcos.nutritionist/